Can you mix BPC-157 and TB-500 in one syringe?

Some people co-draw the two already-reconstituted solutions into one syringe right before injecting, since both are often reconstituted in plain bacteriostatic water and sit in a similar near-neutral pH range. That is different from dissolving both powders in one vial, which is generally avoided. Any combined draw that turns cloudy or shows particles should be discarded, and these decisions belong with a clinician.

What is the difference between co-drawing and co-reconstituting?

Co-drawing means pulling two separately reconstituted vials into one syringe just before use, so contact is seconds. Co-reconstituting means dissolving two dry powders together in one vial and storing them, so contact lasts days or weeks. The long contact time is why co-reconstituting carries more stability and dosing risk.

Why does pH matter when mixing two peptides?

If two solutions have very different pH, combining them can shift the pH and push a peptide out of solution, which shows up as cloudiness or visible particles. Peptides in a similar, compatible pH range are more likely to stay clear when briefly combined. A peptide that requires an acidic carrier is a warning sign against mixing.

Is it safer to inject two peptides at separate sites?

Using separate vials, separate syringes, and two rotated injection sites is the lowest-variable approach. It keeps each compound's chemistry untouched, each dose independently adjustable, and each timeline traceable. It avoids every mixing question entirely.

How do I calculate the dose for each peptide if I keep them separate?

Reconstitute each vial on its own, then convert each target amount into syringe units using a reconstitution and dosage calculator. For example, a vial at 250 mcg per 10 units means a 250 mcg reference draw is 10 units on a U-100 insulin syringe. Separate vials keep every unit mark a clean single-peptide number.

Reconstitution & Dosing

Can You Mix Two Peptides in One Syringe? (BPC-157 + TB-500 and More)

A neutral reference on when two reconstituted peptides can share a syringe draw, why they should never share a vial, and how the separate-site approach keeps the math clean.

Michael ManevichJune 6, 20264 min read

"Can you mix two peptides in one syringe?" usually means one of two very different things: drawing two already-reconstituted compounds into the same barrel right before an injection, or dissolving two dry powders together in the same vial. These are not the same question, and the answer changes depending on which one is being asked.

This is general reference information for handling research compounds, not medical advice. Peptides are research chemicals not approved for human consumption, and any decision belongs with a licensed clinician. What follows is the chemistry and the math, framed neutrally.

Co-drawing vs co-reconstituting

The distinction matters because the risks are different.

Co-drawing: two separately reconstituted vials, each pulled into one syringe just before use. Contact time is seconds to minutes.
Co-reconstituting: two dry powders dissolved together in a single vial, then stored for days or weeks. Contact time is long, and reactions have time to happen.

Most of the caution online is really about co-reconstituting. Co-drawing is the lower-variable scenario, and it is where pH matching comes in.

When co-drawing can be okay: matching pH

Two reconstituted peptides drawn into one syringe are most likely to stay stable when their solutions sit in a similar pH range and neither is known to react with the other. BPC-157 and TB-500 are the classic example people pair, since both are commonly reconstituted in plain bacteriostatic water and tend to land in a near-neutral range.

The general principle: if one solution is acidic and the other is near-neutral or basic, combining them can shift pH and push a peptide toward falling out of solution (cloudiness or visible particles). A peptide that needs an acidic carrier is a red flag for mixing.

Why you should never co-reconstitute

Dissolving two powders in the same vial creates problems that a quick co-draw does not:

Stability over time. Days of contact give degradation and peptide-to-peptide interactions room to occur. A 30-second co-draw does not.
You lose dosing flexibility. Once two peptides share a vial at a fixed ratio, you can never adjust one without the other. Separate vials let each concentration change independently.
Troubleshooting becomes impossible. If a combined vial goes cloudy, you cannot tell which peptide failed or whether they reacted. Separate vials isolate the variable.
Concentration math gets messy. Two actives in one volume means every unit on the syringe represents a blend, not a clean single-peptide dose.

For these reasons, reconstitute each peptide in its own vial. Use a reconstitution calculator to set each concentration separately, and see how to reconstitute peptides for the per-vial procedure.

The safer approach: separate sites, separate syringes

The lowest-variable method skips mixing entirely. Reconstitute separately, draw separately, and inject at two rotated sites. This keeps each compound's chemistry untouched and each dose independently traceable. See peptide injection sites and rotation for spacing general guidance.

Worked example with separate vials. Say a BPC-157 vial is reconstituted to 250 mcg per 10 units and a TB-500 vial to 1 mg per 20 units:

BPC-157 at 250 mcg per 10 units: a 250 mcg reference draw is 10 units on a U-100 insulin syringe.
TB-500 at 1 mg per 20 units: a 1 mg reference draw is 20 units.
Separate draws mean each number is clean. A combined vial would force you to back-calculate a blended unit mark every time.

Run each compound through the peptide dosage calculator to convert mg or mcg into syringe units, and check how to read an insulin syringe for peptides so each mark is read correctly. Logging both injections in a tracking app keeps the two timelines separate.

Quick reference

Co-reconstituting (one vial, two powders): avoid. Long contact, lost flexibility, no troubleshooting.
Co-drawing (one syringe, two reconstituted vials): possible when pH ranges are compatible and neither is known to react; use immediately, never store the combined draw.
Separate sites: lowest variable, fully traceable, keeps each dose clean.
Any cloudiness, haze, or particles: discard, do not inject.

Try the reconstitution calculator

Open the calculator

Frequently asked questions

Can you mix BPC-157 and TB-500 in one syringe?: Some people co-draw the two already-reconstituted solutions into one syringe right before injecting, since both are often reconstituted in plain bacteriostatic water and sit in a similar near-neutral pH range. That is different from dissolving both powders in one vial, which is generally avoided. Any combined draw that turns cloudy or shows particles should be discarded, and these decisions belong with a clinician.
What is the difference between co-drawing and co-reconstituting?: Co-drawing means pulling two separately reconstituted vials into one syringe just before use, so contact is seconds. Co-reconstituting means dissolving two dry powders together in one vial and storing them, so contact lasts days or weeks. The long contact time is why co-reconstituting carries more stability and dosing risk.
Why does pH matter when mixing two peptides?: If two solutions have very different pH, combining them can shift the pH and push a peptide out of solution, which shows up as cloudiness or visible particles. Peptides in a similar, compatible pH range are more likely to stay clear when briefly combined. A peptide that requires an acidic carrier is a warning sign against mixing.
Is it safer to inject two peptides at separate sites?: Using separate vials, separate syringes, and two rotated injection sites is the lowest-variable approach. It keeps each compound's chemistry untouched, each dose independently adjustable, and each timeline traceable. It avoids every mixing question entirely.
How do I calculate the dose for each peptide if I keep them separate?: Reconstitute each vial on its own, then convert each target amount into syringe units using a reconstitution and dosage calculator. For example, a vial at 250 mcg per 10 units means a 250 mcg reference draw is 10 units on a U-100 insulin syringe. Separate vials keep every unit mark a clean single-peptide number.

Keep this calculation in your pocket

Stackr saves every vial you reconstitute, tracks doses remaining, and reminds you to reorder before you run out. The reference app for people who take their protocol seriously.

Why Stackr

Coming soon

Educational tool only, not medical advice. Peptides are research chemicals, not for human consumption. Full disclaimer.